Cervical cancer is the most common gynecologic malignancy. Since cervical cancer has a long precancerous stage, cervical cytology screening allows for early diagnosis and early treatment of cervical cancer. Cervical cancer screening is included in the annual gynecological checkup, and one of the two cancer screening tests conducted in China is to screen for cervical cancer. Cervical TCT is the most common and advanced screening tool for the general population. During the gynecological examination, the doctor uses a vaginal speculum to open the vagina, expose the cervix, and use a special sampler to collect a cervical cell sample, which is placed in a vial with preserved fluid and sent to the laboratory for cytological classification and diagnosis. The results of the screening test are usually available in 1-2 weeks. If the TCT results show lesions, colposcopy and pathological diagnosis usually need to be continued, if the TCT shows no problems, regular check-ups are sufficient. Avoid vaginal medication and douching 3 days before this test, do not have intercourse the night before the test, avoid menstruation, and if you have more serious vaginal inflammation, treat it first to avoid affecting the results. Since cervical cytology smear examination has been commonly carried out at home and abroad, the incidence of cervical cancer has decreased significantly and the mortality rate has also been decreasing, so women should pay attention to cervical cancer screening. The screening of cervical lesions will become more accurate if the examination can be done simultaneously with HPV-DNA which screens the cervix for having unmanned papilloma virus infection.
Support Us
Discussion
Share your experience, or seek help from fellow patients.
